Treatment with double dose of omeprazole increases β-endorphin plasma level in patients with coronary artery disease

Archives of Medical Science

Volumn 6, Issue 2, 2010, Pages 201-207

  Budzyński, Jacek ^a   Pulkowski, Grzegorz ^b   Kłopocka, Maria ^a   Augustyńska, Beata ^a   Sinkiewicz, Anna ^b   Suppan, Karol ^a   Fabisiak, Jacek ^a   Majer, Marcin ^b   Świa̧tkowski, Maciej ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Dr Jan Biziel University Hospital No 2   (Poland)

Author keywords

endorphin; Chest pain; Coronary artery disease; Omeprazole test

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ENDORPHIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; OMEPRAZOLE; PLACEBO;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 77951949211     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.13896     Document Type: Article

References (31)

1. Fass R, Navarro-Rodriguez T. Noncardiac chest pain. J Clin Gastroenterol 2008; 42: 636-646
2. Dickman R, Fass R. Noncardiac chest pain. Clin Gastroenterol Hepatol 2006; 4: 558-563
3. Świa̧tkowski M, Budzyński J, Kłopocka M, et al. Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease. Med Sci Monit 2004; 10: CR524-9.
4. Flook N, Jones R, Vakil N. Approach to gastroesophageal reflux disease in primary care: Putting the Montreal definition into practice. Can Fam Physician 2008; 54: 701-705 (Pubitemid 351838492)
5. Dickman R, Emmons S, Cui H, et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2005; 22: 547-555 (Pubitemid 41360801)
6. Bautista J, Fullerton H, Briseno M, Cui H, Fass R. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain-a randomized, double-blind, placebo controlled, crossover trial. Aliment Pharmacol Ther 2004; 19: 1123-1130 (Pubitemid 38703525)
7. Budzyński J, Kłopocka M, Pulkowski G, et al. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease - a randomised, double-blind, placebo controlled, crossover trial. Int J Cardiol 2008; 127: 233-239 (Pubitemid 351787800)
8. Drewes AM, Arendt-Nielsen L, Funch-Jensen P, Gregersen H. Experimental human pain models in gastro-esophageal reflux disease and unexplained chest pain. World J Gastroenterol 2006; 12: 2806-2817 (Pubitemid 43805448)
9. Sifrim D, Mittal R, Fass R, et al. Review article: acidity and volume of the refluxate in the genesis of gastrooesophageal reflux disease symptoms. Aliment Pharmacol Ther 2007; 25: 1003-1017
10. Chauhan A, Petch MC, Schofield PM. Cardio-oesophageal reflex in humans as a mechanism for "linked angina". Eur Heart J 1996; 17: 407-413
11. Dobrzycki S, Baniukiewicz A, Korecki J, et al. Does gastroesophageal reflux provoke the myocardial ischemia in patients with CAD? Int J Cardiol 2005; 104: 67-72.
12. Dickman R, Schiff E, Holland A, et al. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther 2007; 26: 1333-1344 (Pubitemid 350045612)
13. de Jong W, Petty MA, Sitsen JM. Role of opioid peptides in brain mechanisms regulating blood pressure. Chest 1983; 83: 306-308 (Pubitemid 13153303)
14. Jarmukli NF, Ahn J, Iranmanesh A, Russell DC. Effect of raised plasma beta endorphin concentrations on peripheral pain and angina thresholds in patients with stable angina. Heart 1999; 82: 204-209 (Pubitemid 29362872)
15. Falcone C, Specchia G, Rondanelli R, et al. Correlation between beta-endorphin plasma levels and anginal symptoms in patients with coronary artery disease. J Am Coll Cardiol 1988; 11: 719-723 (Pubitemid 18092178)
16. Krittayaphong R, Light KC, Golden RN, Finkel JB, Sheps DS. Relationship among depression scores, beta-endorphin, and angina pectoris during exercise in patients with coronary artery disease. Clin J Pain 1996; 12: 126-133 (Pubitemid 26181071)
17. Light KC, Herbst MC, Bragdon EE, et al. Depression and type A behavior pattern in patients with coronary artery disease: relationships to painful versus silent myocardial ischemia and beta-endorphin responses during exercise. Psychosom Med 1991; 53: 669-683
18. Sadigh B, Berglund M, Fillingim RB, Sheps D, Sylvén C. beta-Endorphin modulates adenosine provoked chest pain in men, but not in women-a comparison between patients with ischemic heart disease and healthy volunteers. Clin J Pain 2007; 23: 750-755 (Pubitemid 351339409)
19. Sadigh-Lindell B, Sylvén C, Berglund M, Eriksson BE. Role of adenosine and opioid-receptor mechanisms for pain in patients with silent myocardial ischemia or angina pectoris: a double-blind, placebo-controlled study. J Cardiovasc Pharmacol 2003; 42: 757-763 (Pubitemid 37467098)
20. Tonnarini GF, Delle Fave G, Chianelli M, Mariani P, Negri M. Beta-endorphin in silent duodenal ulcer. Eur J Gastroenterol Hepatol 1995; 7: 357-360
21. Ring C, France CR, al'Absi M, et al. Effects of opioid blockade with naltrexone and distraction on cold and ischemic pain in hypertension. J Behav Med 2007; 30: 59-68. (Pubitemid 46197888)
22. Oldroyd KG, Harvey K, Gray CE, Beastall GH, Cobbe SM. Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia. Br Heart J 1992; 67: 230-235
23. Stefano GB, Zhu W, Cadet P, Bilfinger TV, Mantione K. Morphine enhances nitric oxide release in the mammalian gastrointestinal tract via the micro(3) opiate receptor subtype: a hormonal role for endogenous morphine. J Physiol Pharmacol 2004; 55: 279-288
24. Sarkar S, Thompson DG, Woolf CJ, Hobson AR, Millane T, Aziz Q. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol 2004; 99: 1998-2006. (Pubitemid 39421246)
25. Walters K, Rait G, Petersen I, Williams R, Nazareth I. Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database. Eur Heart J 2008; 29: 2981-2988
26. Machała W, Rysz J, Gaszyński T, Gaszyński W. Analgetic and sedative agents administered to the patients in life-threatening conditions. Arch Med Sci 2005; 1: 138-143
27. Isomoto H, Nishi Y, Kanazawa Y, et al. Immune and inflammatory responses in GERD and lansoprazole. J Clin Biochem Nutr 2007; 41: 84-91. (Pubitemid 47529303)
28. Verma-Gandhu M, Verdu EF, Cohen-Lyons D, Collins SM. Lymphocyte-mediated regulation of beta-endorphin in the myenteric plexus. Am J Physiol Gastrointest Liver Physiol 2007; 292: G344-8. (Pubitemid 46090277)
29. Verma-Gandhu M, Verdu EF, Bercik P, et al. Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut 2007; 56: 358-364 (Pubitemid 46579764)
30. Carlos MA, Du Souich P, Carlos R, Suarez E, Lukas JC, Calvo R. Effect of omeprazole on oral and intravenous RS-methadone pharmacokinetics and pharmacodynamics in the rat. J Pharm Sci 2002; 91: 1627-1638 (Pubitemid 34680225)
31. Chandrashekhar SM, Chakrabarti A, Garg SK. Pharmacodynamic interactions of omeprazole with CNS active drugs in rats. Indian J Physiol Pharmacol 1995; 39: 74-76